|
|
||||||||
J Thorac Cardiovasc Surg 1996;112:1634-1639
© 1996 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
From the Division of Cardiothoracic Surgery and Pediatric Cardiology, Departments of Surgery and Pediatrics, Primary Children's Medical Center and the University of Utah, Salt Lake City, Utah.
Received for publication May 6, 1996 Revisions requested June 20, 1996; revisions received July 22, 1996 Accepted for publication July 24, 1996. Address for reprints: John A. Hawkins, MD, Cardiothoracic Surgery, Primary Children's Medical Center, 100 North Medical Dr., Salt Lake City, UT 84113.
Abstract
Objective: The purpose of this study was to compare cost and efficacy of surgical closure of patent ductus arteriosus using new critical pathway methods with outpatient transcatheter coil occlusion of patent ductus arteriosus.
Methods: Surgical techniques included a transaxillary, muscle-sparing horacotomy, triple ligation of the patent ductus arteriosus, no chest tube, and discharge from the hospital within 24 hours. Transcatheter coil occlusion of patent ductus arteriosus was done as an outpatient procedure. Costs were compared with inclusion of all hospital and professional charges.
Results: From July 1994 until March 1996, 20 patients underwent coil occlusion of patent ductus arteriosus and 20 patients underwent surgical closure of patent ductus arteriosus. Duration of hospitalization was significantly less for the patients receiving coil occlusion (11 ± 6 hours) as compared with that for the patients having surgical ligation (28 ± 7 hours, p < 0.05). Total charges were similar for surgical ligation ($7101 ± $408) as compared with those for coil occlusion ($7104 ± $886, p > 0.05). Morbidity in coil occlusion included inability to occlude the patent ductus arteriosus in two patients (2/20, 10%) and residual patency in two patients (2/18, 11%). Morbidity in the surgical group included nausea and vomiting necessitating hospitalization for more than 36 hours in one patient (1/20, 5%), transient left recurrent laryngeal nerve palsy in one (1/20, 5%), and pneumothorax in two patients (2/20, 10%). There were no instances of residual patency in the surgical group.
Conclusions: Transaxillary thoracotomy without tube thoracostomy and with critical pathway methods allows safe and effective ligation of a patent ductus arteriosus with early hospital discharge. This surgical method has similar cost, higher efficacy rate, and applicability in all patients as compared with newer transcatheter coil occlusion techniques for closure of a patent ductus arteriosus. (J THORAC CARDIOVASC SURG 1996;112:1634-9)
This article has been cited by other articles:
![]() |
D. M. McMullan, A. Moulick, and R. A. Jonas Late Embolization of Amplatzer Patent Ductus Arteriosus Occlusion Device With Thoracic Aorta Embedment Ann. Thorac. Surg., March 1, 2007; 83(3): 1177 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Schneider and J. W. Moore Patent Ductus Arteriosus Circulation, October 24, 2006; 114(17): 1873 - 1882. [Full Text] [PDF] |
||||
![]() |
S. Dutta and C. T. Albanese Minimal Access Surgery in the Neonate NeoReviews, August 1, 2006; 7(8): e400 - e409. [Full Text] [PDF] |
||||
![]() |
A. Rangel, H. Perez-Redondo, J. Farell, M. N. Basave, and C. Zamora Division or Occlusion of Patent Ductus Arteriosus? Angiology, November 1, 2003; 54(6): 695 - 700. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |